---  
layout: startup_page  
title: "Azafaros"  
id: "azafaros.com"  
permalink: "/azafarosazafaros.com05132025/"  
website: "https://www.azafaros.com/"  
funding_round: "Series B"  
funding_amount: "€132M"  
investors: "Jeito Capital, Forbion Growth, Seroba, Pictet Group, Forbion Ventures, Schroders Capital, BioGeneration Ventures (BGV)"  
about: "Azafaros is a clinical-stage company focused on developing disease-modifying therapeutics to treat rare lysosomal storage disorders. The company is developing nizubaglustat, a potential treatment for Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses, which is scheduled to enter Phase 3 studies. Azafaros aims to offer new treatment options for patients with severe rare genetic diseases."  
markets: "Biotech, Therapeutics, Health Care"  
hq: "Leiden, Zuid-Holland, The Netherlands"  
founded_year: "2018"  
linkedin: "https://www.linkedin.com/company/azafaros-b-v"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/azafaros"  
pitchbook: "https://pitchbook.com/profiles/company/231257-26"  

date_display: "13-May-2025"  
date: "2025-05-13"

# SEO Optimization  
meta_title: "Azafaros - Series B Funding (€132M)"  
meta_description: "Azafaros, Azafaros is a clinical-stage company focused on developing disease-modifying therapeutics to treat rare lysosomal storage disorders. The company is de..."  
meta_keywords: "Azafaros, Biotech, Therapeutics, Health Care, Series B funding"  
canonical_url: "https://startup.projectstartups.com/azafarosazafaros.com05132025/"  
---